Viewing Study NCT03209232


Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2026-02-25 @ 10:09 PM
Study NCT ID: NCT03209232
Status: TERMINATED
Last Update Posted: 2021-10-01
First Post: 2017-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Infliximab Accelerated Induction in Moderate to Severe Pediatric UC
Sponsor: Schneider Children's Medical Center, Israel
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: INDUCE
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators